Long-Acting Injectables market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Long-Acting Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Small and Middle Sized Molecule Large Sized Molecule Segment by Application Schizophrenia Other Psychotic Disorders By Company Eli Lilly Pfizer GlaxoSmithKline Johnson & Johnson Lupin Zogenix DURECT Medincel By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Small and Middle Sized Molecule 1.2.3 Large Sized Molecule 1.3 Market by Application 1.3.1 Global Long-Acting Injectables Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Schizophrenia 1.3.3 Other Psychotic Disorders 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Long-Acting Injectables Market Perspective (2017-2028) 2.2 Long-Acting Injectables Growth Trends by Region 2.2.1 Long-Acting Injectables Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Long-Acting Injectables Historic Market Size by Region (2017-2022) 2.2.3 Long-Acting Injectables Forecasted Market Size by Region (2023-2028) 2.3 Long-Acting Injectables Market Dynamics 2.3.1 Long-Acting Injectables Industry Trends 2.3.2 Long-Acting Injectables Market Drivers 2.3.3 Long-Acting Injectables Market Challenges 2.3.4 Long-Acting Injectables Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Long-Acting Injectables Players by Revenue 3.1.1 Global Top Long-Acting Injectables Players by Revenue (2017-2022) 3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2017-2022) 3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Long-Acting Injectables Revenue 3.4 Global Long-Acting Injectables Market Concentration Ratio 3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2021 3.5 Long-Acting Injectables Key Players Head office and Area Served 3.6 Key Players Long-Acting Injectables Product Solution and Service 3.7 Date of Enter into Long-Acting Injectables Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Long-Acting Injectables Breakdown Data by Type 4.1 Global Long-Acting Injectables Historic Market Size by Type (2017-2022) 4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2023-2028) 5 Long-Acting Injectables Breakdown Data by Application 5.1 Global Long-Acting Injectables Historic Market Size by Application (2017-2022) 5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Long-Acting Injectables Market Size (2017-2028) 6.2 North America Long-Acting Injectables Market Size by Type 6.2.1 North America Long-Acting Injectables Market Size by Type (2017-2022) 6.2.2 North America Long-Acting Injectables Market Size by Type (2023-2028) 6.2.3 North America Long-Acting Injectables Market Share by Type (2017-2028) 6.3 North America Long-Acting Injectables Market Size by Application 6.3.1 North America Long-Acting Injectables Market Size by Application (2017-2022) 6.3.2 North America Long-Acting Injectables Market Size by Application (2023-2028) 6.3.3 North America Long-Acting Injectables Market Share by Application (2017-2028) 6.4 North America Long-Acting Injectables Market Size by Country 6.4.1 North America Long-Acting Injectables Market Size by Country (2017-2022) 6.4.2 North America Long-Acting Injectables Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Long-Acting Injectables Market Size (2017-2028) 7.2 Europe Long-Acting Injectables Market Size by Type 7.2.1 Europe Long-Acting Injectables Market Size by Type (2017-2022) 7.2.2 Europe Long-Acting Injectables Market Size by Type (2023-2028) 7.2.3 Europe Long-Acting Injectables Market Share by Type (2017-2028) 7.3 Europe Long-Acting Injectables Market Size by Application 7.3.1 Europe Long-Acting Injectables Market Size by Application (2017-2022) 7.3.2 Europe Long-Acting Injectables Market Size by Application (2023-2028) 7.3.3 Europe Long-Acting Injectables Market Share by Application (2017-2028) 7.4 Europe Long-Acting Injectables Market Size by Country 7.4.1 Europe Long-Acting Injectables Market Size by Country (2017-2022) 7.4.2 Europe Long-Acting Injectables Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Long-Acting Injectables Market Size (2017-2028) 8.2 Asia-Pacific Long-Acting Injectables Market Size by Type 8.2.1 Asia-Pacific Long-Acting Injectables Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Long-Acting Injectables Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Long-Acting Injectables Market Share by Type (2017-2028) 8.3 Asia-Pacific Long-Acting Injectables Market Size by Application 8.3.1 Asia-Pacific Long-Acting Injectables Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Long-Acting Injectables Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Long-Acting Injectables Market Share by Application (2017-2028) 8.4 Asia-Pacific Long-Acting Injectables Market Size by Region 8.4.1 Asia-Pacific Long-Acting Injectables Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Long-Acting Injectables Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Long-Acting Injectables Market Size (2017-2028) 9.2 Latin America Long-Acting Injectables Market Size by Type 9.2.1 Latin America Long-Acting Injectables Market Size by Type (2017-2022) 9.2.2 Latin America Long-Acting Injectables Market Size by Type (2023-2028) 9.2.3 Latin America Long-Acting Injectables Market Share by Type (2017-2028) 9.3 Latin America Long-Acting Injectables Market Size by Application 9.3.1 Latin America Long-Acting Injectables Market Size by Application (2017-2022) 9.3.2 Latin America Long-Acting Injectables Market Size by Application (2023-2028) 9.3.3 Latin America Long-Acting Injectables Market Share by Application (2017-2028) 9.4 Latin America Long-Acting Injectables Market Size by Country 9.4.1 Latin America Long-Acting Injectables Market Size by Country (2017-2022) 9.4.2 Latin America Long-Acting Injectables Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Long-Acting Injectables Market Size (2017-2028) 10.2 Middle East & Africa Long-Acting Injectables Market Size by Type 10.2.1 Middle East & Africa Long-Acting Injectables Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Long-Acting Injectables Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Long-Acting Injectables Market Share by Type (2017-2028) 10.3 Middle East & Africa Long-Acting Injectables Market Size by Application 10.3.1 Middle East & Africa Long-Acting Injectables Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Long-Acting Injectables Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Long-Acting Injectables Market Share by Application (2017-2028) 10.4 Middle East & Africa Long-Acting Injectables Market Size by Country 10.4.1 Middle East & Africa Long-Acting Injectables Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Long-Acting Injectables Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Company Details 11.1.2 Eli Lilly Business Overview 11.1.3 Eli Lilly Long-Acting Injectables Introduction 11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2017-2022) 11.1.5 Eli Lilly Recent Developments 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Long-Acting Injectables Introduction 11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2017-2022) 11.2.5 Pfizer Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Company Details 11.3.2 GlaxoSmithKline Business Overview 11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction 11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2017-2022) 11.3.5 GlaxoSmithKline Recent Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Long-Acting Injectables Introduction 11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2017-2022) 11.4.5 Johnson & Johnson Recent Developments 11.5 Lupin 11.5.1 Lupin Company Details 11.5.2 Lupin Business Overview 11.5.3 Lupin Long-Acting Injectables Introduction 11.5.4 Lupin Revenue in Long-Acting Injectables Business (2017-2022) 11.5.5 Lupin Recent Developments 11.6 Zogenix 11.6.1 Zogenix Company Details 11.6.2 Zogenix Business Overview 11.6.3 Zogenix Long-Acting Injectables Introduction 11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2017-2022) 11.6.5 Zogenix Recent Developments 11.7 DURECT 11.7.1 DURECT Company Details 11.7.2 DURECT Business Overview 11.7.3 DURECT Long-Acting Injectables Introduction 11.7.4 DURECT Revenue in Long-Acting Injectables Business (2017-2022) 11.7.5 DURECT Recent Developments 11.8 Medincel 11.8.1 Medincel Company Details 11.8.2 Medincel Business Overview 11.8.3 Medincel Long-Acting Injectables Introduction 11.8.4 Medincel Revenue in Long-Acting Injectables Business (2017-2022) 11.8.5 Medincel Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Small and Middle Sized Molecule Table 3. Key Players of Large Sized Molecule Table 4. Global Long-Acting Injectables Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Long-Acting Injectables Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Long-Acting Injectables Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Long-Acting Injectables Market Share by Region (2017-2022) Table 8. Global Long-Acting Injectables Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Long-Acting Injectables Market Share by Region (2023-2028) Table 10. Long-Acting Injectables Market Trends Table 11. Long-Acting Injectables Market Drivers Table 12. Long-Acting Injectables Market Challenges Table 13. Long-Acting Injectables Market Restraints Table 14. Global Long-Acting Injectables Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Long-Acting Injectables Revenue Share by Players (2017-2022) Table 16. Global Top Long-Acting Injectables by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2021) Table 17. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Long-Acting Injectables Product Solution and Service Table 21. Date of Enter into Long-Acting Injectables Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2017-2022) Table 25. Global Long-Acting Injectables Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Long-Acting Injectables Revenue Market Share by Type (2023-2028) Table 27. Global Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Long-Acting Injectables Revenue Share by Application (2017-2022) Table 29. Global Long-Acting Injectables Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Long-Acting Injectables Revenue Share by Application (2023-2028) Table 31. North America Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Long-Acting Injectables Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Long-Acting Injectables Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Long-Acting Injectables Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Long-Acting Injectables Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million) Table 61. Eli Lilly Company Details Table 62. Eli Lilly Business Overview Table 63. Eli Lilly Long-Acting Injectables Product Table 64. Eli Lilly Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 65. Eli Lilly Recent Developments Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Long-Acting Injectables Product Table 69. Pfizer Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 70. Pfizer Recent Developments Table 71. GlaxoSmithKline Company Details Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Long-Acting Injectables Product Table 74. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 75. GlaxoSmithKline Recent Developments Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Long-Acting Injectables Product Table 79. Johnson & Johnson Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 80. Johnson & Johnson Recent Developments Table 81. Lupin Company Details Table 82. Lupin Business Overview Table 83. Lupin Long-Acting Injectables Product Table 84. Lupin Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 85. Lupin Recent Developments Table 86. Zogenix Company Details Table 87. Zogenix Business Overview Table 88. Zogenix Long-Acting Injectables Product Table 89. Zogenix Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 90. Zogenix Recent Developments Table 91. DURECT Company Details Table 92. DURECT Business Overview Table 93. DURECT Long-Acting Injectables Product Table 94. DURECT Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 95. DURECT Recent Developments Table 96. Medincel Company Details Table 97. Medincel Business Overview Table 98. Medincel Long-Acting Injectables Product Table 99. Medincel Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million) Table 100. Medincel Recent Developments Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Long-Acting Injectables Market Share by Type: 2021 VS 2028 Figure 2. Small and Middle Sized Molecule Features Figure 3. Large Sized Molecule Features Figure 4. Global Long-Acting Injectables Market Share by Application: 2021 VS 2028 Figure 5. Schizophrenia Case Studies Figure 6. Other Psychotic Disorders Case Studies Figure 7. Long-Acting Injectables Report Years Considered Figure 8. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Long-Acting Injectables Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Long-Acting Injectables Market Share by Region: 2021 VS 2028 Figure 11. Global Long-Acting Injectables Market Share by Players in 2021 Figure 12. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2021 Figure 14. North America Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 16. North America Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 17. North America Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 18. United States Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 22. Europe Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 23. Europe Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 24. Germany Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Long-Acting Injectables Market Size Share by Region (2017-2028) Figure 34. China Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 42. Latin America Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 43. Latin America Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 44. Mexico Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Long-Acting Injectables Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Long-Acting Injectables Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Long-Acting Injectables Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Long-Acting Injectables Market Size Share by Country (2017-2028) Figure 50. Turkey Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 54. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 55. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 56. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 57. Lupin Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 58. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 59. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 60. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed